Skip to main content
Equibles

BARCLAYS PLC

Position in DYAI — Dyadic International Inc

CIK 312069 LONDON, X0
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$142
+$83 QoQ
Shares Held
159
+120.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 39 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. DYAI ranks #426 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in DYAI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $142 159
2026-03-31 $59 72
2025-12-31 $67 72
2025-09-30 $84 72
2025-06-30 $71 72
2025-03-31 $97 72
2024-12-31 $126 72
2024-09-30 $74 72
2024-06-30 $106 72
2024-03-31 $120 72
2023-12-31 $115 72
2023-09-30 $138 72
2023-06-30 $138 72
2023-03-31 $128 72
2022-12-31 $88 72
2022-09-30 $137 72
2022-06-30 $219 72
2022-03-31 $22,722 7,549
2021-12-31 $34,121 7,549
2021-09-30 $57,751 10,387
2021-06-30 $51,225 14,269
2021-03-31 $129,942 23,669
2020-12-31 $74,098 13,773
2020-09-30 $126,773 16,747
2020-06-30 $157,179 18,150